Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Zambon Co. SPA

https://www.zambon.com/en

Latest From Zambon Co. SPA

Deal Watch: Celgene Reworks Alliance With Jounce, Gaining Global Rights To Macrophage-Targeting Candidate

Revised agreement of 2016 collaboration returns all vopratelimab rights to Jounce. Gilead fortifies antiviral pipeline in deals with Novartis, Durect.

Deals M & A

Breath Therapeutics Snapped Up Post Series A By Specialty Company Zambon

Italy’s privately held Zambon could pay up to 500m to bulk up its respiratory products pipeline, producing a nice return for Breath Therapeutics’ syndicate of European investors.

 

M & A Respiratory

No Panic At Newron Over Delayed Schizophrenia Drug Trial

Although the US FDA raised concerns about a rat toxicity trial, causing shares to slide, Italy's Newron believes the trial delay for schizophrenia therapy evenamide is just a blip.

Drug Safety Neurology

Sun On Course To Launch Safinamide For Parkinson’s In India

Safinamide appears to be headed for a debut on the Indian market, after Sun Pharma received a go-ahead from a key expert panel for the Parkinson’s disease treatment. Pricing of the selective monoamine oxidase B inhibitor and innovator Newron’s stance around the emerging India activity for the product could be interesting to watch.

Launches Neurology
See All

Company Information

  • Industry
  • Diversified
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Zambon Group SPA
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Italy
  • Company Type
  • Midsize European
  • Parent & Subsidiaries
  • Zambon Co. SPA
  • Senior Management
  • Roberto Tascione, CEO
    Giovanni Magnaghi, CFO
    Paola Castellani, Global Medical Officer
  • Contact Info
  • Zambon Co. SPA
    Phone: (39) 02 665241
    Via Lillo del Duca 10
    Bresso (Milan), 20091
    Italy
Advertisement
Advertisement
UsernamePublicRestriction

Register